Andrew Kuykendall, MD - Ironing Out the Challenges of PV: Spotlight on Targeting the Hepcidin Pathway for Addressing Unmet Needs and Enhancing Patient Outcomes
The episode discusses the challenges of Polycythemia Vera and the importance of targeting the Hepcidin pathway to improve patient outcomes.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RPX865. CME/MOC/CPE/AAPA/IPCE credit will be available until May 28, 2027. Ironing Out the Challenges of PV: Spotlight on Targeting the Hepcidin Pathway for Addressing Unmet Needs and Enhancing Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. Disclosure information is available at the beginning of the video presentation.
Sponsors
Takeda Pharmaceuticals U.S.A., Inc.
More episodes of PeerView Clinical Pharmacology CME/CNE/CPE Video